Islam is the only major religion that puts a cap on polygamy, limiting the number of a mans wives to four—provided the husband can do justice to all of them. Although some religions, such as Catholicism for instance, puts a cap on polygamy all together, or even serial monogamy, allowing one spouse until death does them apart, not even accepting divorce. According to the teachings of Islam a Muslim man should have a valid reason and have to get permission from his existing wife (without any force) if he requires to marry again. Islam vehemently abhors any intimate relationship outside the bond of marriage. There is no external sign to show his status as a husband, unless he adopted the tradition of wearing a wedding ring. Hinduism
A Hindu husband traditionally takes his wife to his home. He is expected to provide for her and to prove his abilities to do so. The marriage in Hinduism is a relationship for Seven births (सात जन्मों का सम्बन्ध). Before 1951 there was no divorce allowed in Hindu marriage. In modern times once again after 1951, equal rights for women through society and law jurisdiction is given. In Hinduism, based on the different regions, marriage process is observed differently with the same Saat Pheras around agni kund (light pyre) to be taken to become a husband and wife. The Encyclopædia Britannica mentions that "In Hindu law, the male members of a joint family, together with their wives, widows, and children, are entitled to support out of the joint property."
Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).In June 2010, it was approved in the European Union for severe COPD associated with chronic bronchitis. In February 2011, it gained FDA approval in the United States for reducing COPD exacerbations. Medical uses
Roflumilast is indicated for the treatment of severe chronic obstructive pulmonary disease (COPD) and for the treatment of plaque psoriasis.It is used in the prevention of exacerbations (lung attacks) in severe chronic obstructive pulmonary disease (COPD).A topical formulation of Rolflumilast was recently approved by the U.S. Food and Drug Administration for plaque psoriasis. Adverse effects
Common (1–10% incidence) adverse effects include:
Diarrhea
Weight loss
Nausea
Headache
Insomnia
Decreased appetite
Abdominal pain
Rhinitis
Sinusitis
Urinary tract infection
Depression

References
External links
"Roflumilast". Drug Information Portal. U.S. National Library of Medicine.